fisetin (CID 5281614) - BioAssay Data Summary for Compound
.
BioActivity Outcomes:
Active(88)
 
 
Inactive(215)
 
 
Inconclusive(34)
 
 
Unspecified(78)
 
 
Top Targets:
p450(10)
 
 
 
 
KAT11(8)
 
 
 
GT1 Gtf like(8)
 
 
Tubulin-bindi..(6)
 
 
 
 
Peptidase C1A(6)
 
 
 
 
BioAssay Types:
Confirmatory(235)
 
 
 
 
Literature(104)
 
 
 
 
Screening(10)
 
 
 
BioActivity Types:
Potency(134)
 
 
 
 
IC50(34)
 
 
 
 
EC50(5)
 
 
 
Ki(2)
 
 
SAR
Target summary
Data download

Chemical Probe    Active    Inactive    Inconclusive    Unspecified   

Total Bioassays: 319    Data Row: 415   Total Pages: 9   Display: Page     
Sort: [Click the result table header to sort]
#SubstanceActivityBioAssayTargetLinks
OutcomeTypeValue [μM]
1
[SID103203131]
I50 0.015Inhibition of beef heart mitochondrial NADH oxidase assessed per mg of protein [AID338027, Type: other]
View
2
[SID103203131]
I50 0.045Inhibition of beef heart mitochondrial succinoxidase assessed per mg of protein [AID338028, Type: other]
View
3
[SID103203131]
IC50 0.2Inhibitory effect on the oxidative degradation of membrane lipids (lipid peroxidation assay) in microsomes of rat. [AID180466, Type: Literature]
View
4
[SID103203131]
ID50 0.24Inhibition of Moloney murine leukemia virus reverse transcriptase using (ribocytidylic acid)n(deoxyguanylic acid)12-18 as template primer by liquid scintillation counting [AID339057, Type: other]
View
5
[SID103203131]
ID50 0.28Inhibition of Moloney murine leukemia virus reverse transcriptase using (riboadenylic acid)n(deoxythymidylic acid)12-18 as template primer by liquid scintillation counting [AID339056, Type: other]
View
6
[SID103203131]
IC50 0.35Inhibition of CK2 [AID378676, Type: Literature]
View
7
[SID124883072]
Potency 0.3981qHTS for Inhibitors of Polymerase Kappa [AID588579, Type: confirmatory]DNA polymerase kappa [Homo sapiens] [gi:7705344]
View
8
[SID124883072]
Potency 0.3981qHTS for Inhibitors of Polymerase Kappa [AID588579, Type: confirmatory]DNA polymerase kappa [Homo sapiens] [gi:7705344]
View
9
[SID103203131]
IC50 0.42Inhibition of glycogen synthase kinase 3 [AID240981, Type: Literature]
View
10
[SID103203131]
I50 0.48Inhibition of rat liver mitochondrial ATPase assessed per mg of protein [AID338025, Type: other]
View
11
[SID124883071]
Potency 0.5623qHTS for Inhibitors of Polymerase Kappa [AID588579, Type: confirmatory]DNA polymerase kappa [Homo sapiens] [gi:7705344]
View
12
[SID124883071]
Potency 0.5623qHTS for Inhibitors of Polymerase Kappa [AID588579, Type: confirmatory]DNA polymerase kappa [Homo sapiens] [gi:7705344]
View
13
[SID103203131]
IC50 0.57Inhibition of Cyclin-dependent kinase 5-p25nck5a [AID241232, Type: Literature]
View
14
[SID103203131]
IC50 0.79Inhibition of cyclin-dependent kinase 1/cyclinB [AID241206, Type: Literature]
View
15
[SID103203131]
IC50 0.85Inhibition of human cyclin-dependent kinase 6 complex with a virus-encoded cyclin from herpesvirus saimiri (Vcyclin) [AID242481, Type: Literature]Cyclin-dependent kinase 6 [gi:266423]
View
16
[SID26749675]
Potency 0.8913qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1) [AID2517, Type: confirmatory]Chain A, Human Ape1 Endonuclease With Bound Abasic Dna And Mn2+ Ion [gi:6980812]
View
17
[SID26749675]
Potency 0.8913Confirmation qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1) [AID2572, Type: confirmatory]Chain A, Human Ape1 Endonuclease With Bound Abasic Dna And Mn2+ Ion [gi:6980812]
View
18
[SID103203131]
IC50 0.95Inhibition of 12-hLO [AID309798, Type: Literature]
View
19
[SID103203131]
IC50 1Inhibition of FabI [AID265759, Type: Literature]Enoyl-acyl-carrier protein reductase precursor [gi:74844868]
View
20
[SID103203131]
IC50 1Inhibition of Plasmodium falciparum FabI [AID494830, Type: Literature]
View
21
[SID11113263]
Potency 1.2589qHTS Assay for Inhibitors of HADH2 (Hydroxyacyl-Coenzyme A Dehydrogenase, Type II) [AID886, Type: confirmatory]Chain A, The Structure Of Wild-Type Human Hadh2 (17beta- Hydroxysteroid Dehydrogenase Type 10) Bound [gi:122921310]
View
22
[SID103203131]
IC50 1.4Inhibition of 15-hLO1 [AID309799, Type: Literature]
View
23
[SID103203131]
IC50 1.84Antioxidant activity assessed as superoxide-scavenging activity by nitrite method [AID399341, Type: Literature]
View
24
[SID26753766]
Potency 1.9953qHTS Assay for Inhibitors of 15-hLO (15-human lipoxygenase) [AID887, Type: confirmatory]15-lipoxygenase [Homo sapiens] [gi:1832253]
View
25
[SID26753766]
Potency 1.9953qHTS Assay for Inhibitors of 15-hLO (15-human lipoxygenase) [AID887, Type: confirmatory]15-lipoxygenase [Homo sapiens] [gi:1832253]
View
26
[SID103203131]
IC50 2Inhibition of FabZ [AID265758, Type: Literature]Beta-hydroxyacyl-ACP dehydratase precursor (Fatty acid synthesis protein) [gi:74844869]
View
27
[SID103203131]
EC50 2Neuroprotective activity in New Zealand white rabbit small clot embolism model assessed as reduction in stroke-induced behavioural deficits at 50 mg/kg, iv administered 5 mins post-embolization measured after 24 hrs [AID646594, Type: Literature]
View
28
[SID11113262]
Potency 2.5119qHTS Assay for Inhibitors of HADH2 (Hydroxyacyl-Coenzyme A Dehydrogenase, Type II) [AID886, Type: confirmatory]Chain A, The Structure Of Wild-Type Human Hadh2 (17beta- Hydroxysteroid Dehydrogenase Type 10) Bound [gi:122921310]
View
29
[SID103203131]
EC50 2.8Neuroprotective effect against iodoacetic acid-induced ischemia in mouse HT22 cells treated simultaneously with iodoacetic acid for 2 hrs followed by incubation in fresh medium containing drug alone for 20 hrs measured after 4 hrs by MTT assay [AID397977, Type: Literature]
View
30
[SID26749675]
Potency 2.8184Counterscreen for APE1 Inhibitors: Fluorescent Dye Displacement Assay [AID2564, Type: confirmatory]
View
31
[SID103203131]
EC50 3Neuroprotective activity in mouse HT22 cells assessed as reduction in IAA-induced ischemia after 24 hrs by MTT assay [AID646588, Type: Literature]
View
32
[SID26749675]
Potency 3.1623qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1) [AID2549, Type: confirmatory]Chain A, Structure Of Human Recq-Like Helicase In Complex With A Dna Substrate [gi:282403581]
View
33
[SID103203131]
IC50 3.7Inhibition of procoagulant activity in monocyte from human blood assessed as counteraction of IL1-induced tissue factor expression after 18 hrs [AID400608, Type: Literature]
View
34
[SID103203131]
IC50 4.1Inhibition of FabG [AID265760, Type: Literature]3-oxoacyl-acyl-carrier protein reductase precursor [gi:75020671]
View
35
[SID103203131]
IC50 4.33Inhibition of xanthine oxidase assessed as decrease in uric acid production by spectrophotometry [AID399340, Type: Literature]
View
36
[SID103203131]
IC50 5Inhibition of CDK2 [AID298693, Type: Literature]
View
37
[SID26749675]
Potency 5.0119qHTS Assay for Inhibitors of 15-hLO (15-human lipoxygenase) [AID887, Type: confirmatory]15-lipoxygenase [Homo sapiens] [gi:1832253]
View
38
[SID26749675]
Potency 5.0119qHTS Assay for Inhibitors of 15-hLO (15-human lipoxygenase) [AID887, Type: confirmatory]15-lipoxygenase [Homo sapiens] [gi:1832253]
View
39
[SID26753766]
Potency 5.0119qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding [AID1460, Type: confirmatory]Microtubule-associated protein tau [Homo sapiens] [gi:92096784]
View
40
[SID26753766]
Potency 5.0119qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding [AID1460, Type: confirmatory]Microtubule-associated protein tau [Homo sapiens] [gi:92096784]
View
41
[SID124883072]
Potency 5.9569qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory]
View
42
[SID103203131]
IC50 6.5Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum K1 [AID265762, Type: Literature]
View
43
[SID124883072]
Potency 6.6838qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory]
View
44
[SID103203131]
IC50 8.2Antimalarial activity against chloroquine-sensitive Plasmodium falciparum NF54 [AID494832, Type: Literature]
View
45
[SID103203131]
IC50 8.2Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum NF54 [AID265761, Type: Literature]
View
46
[SID103203131]
IC50 8.5IC50 was measured as concentration required to inhibit 50% of HIV-integrase integration [AID93508, Type: Literature]
View
47
[SID103203131]
IC50 10Inhibition of PI3K [AID378677, Type: Literature]
View
48
[SID26753766]
Potency 11.2202qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium [AID1457, Type: confirmatory]Inositol monophosphatase [gi:44888968]
View
49
[SID26753766]
Potency 11.2202qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium [AID1457, Type: confirmatory]Inositol monophosphatase [gi:44888968]
View
50
[SID26753766]
Potency 12.5893qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay [AID995, Type: confirmatory]mitogen-activated protein kinase 1 [Homo sapiens] [gi:66932916]
View